Sort   by:  
 Page size 
ProteomicsCRTAC1 Enhances the Chemosensitivity of Non-Small Cell Lung Cancer to Cisplatin by Eliciting RyR-mediated Calcium Release and Inhibiting Akt1 Expression
Sensitivity to platinum-based combination chemotherapy is associated with a favorable prognosis in the patients of non-small cell lung cancer (NSCLC). Here, our results obtained from analyses of the Gene Expression Omnibus database of NSCLC patients showed that cartilage acidic protein 1 (CRTAC1) pl...
ORGANISM(S): Homo sapiens (Human) 
2023-08-29 | PXD041782 | Pride
Non-small cell lung cancer  chemosensitivity  crtac1  akt1  ca2+ 
UnknownCRTAC1 identified as a promising diagnosis and prognostic biomarker in lung adenocarcinoma.
Not available
S-EPMC11099150 | biostudies-literature
UnknownPlasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression.
Not available
S-EPMC9977119 | biostudies-literature
UnknownCRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression.
Not available
S-EPMC10460435 | biostudies-literature
UnknownCRTAC1 derived from senescent FLSs induces chondrocyte mitochondrial dysfunction <i>via</i> modulating NRF2/SIRT3 axis in osteoarthritis progression.
Not available
S-EPMC12648000 | biostudies-literature
UnknownThe CRTAC1 Protein in Plasma Is Associated With Osteoarthritis and Predicts Progression to Joint Replacement: A Large-Scale Proteomics Scan in Iceland.
Not available
S-EPMC8596997 | biostudies-literature
UnknownSingle-cell RNA sequencing reveals the CRTAC1+ population actively contributes to the pathogenesis of spinal ligament degeneration by SPP1+ macrophage.
Not available
S-EPMC11634701 | biostudies-literature
GenomicsSingle-cell RNA sequencing reveals the CRTAC1+ population actively contributes to the pathogenesis of spinal ligament degeneration by SPP1+ macrophage
Single-cell RNA sequencing reveals the CRTAC1+ population actively contributes to the pathogenesis of spinal ligament degeneration by SPP1+ macrophage
PRJNA1129430 | ENA
ProteomicsA DIA-MS-based proteomics approach to find potential serum prognostic biomarkers in glioblastoma patients
No blood-based protein biomarkers are currently available for routine clinical use to determine the prognosis of patients with glioblastoma (GB). We performed data-independent acquisition mass spectrometry (DIA-MS)-based proteomics on 96 presurgical serum samples from patients with GB and 30 serum s...
ORGANISM(S): Homo sapiens (Human) 
2025-09-15 | PXD045467 | Pride
Dia-ms Glioblastoma Sera Tumor 
UnknownDecreased plasma cartilage acidic protein 1 in COVID-19.
Not available
S-EPMC10477339 | biostudies-literature
Sort   by:  
 Page size